Taken together, these findings support the idea that coordination between SPARC and its protein partners determines the preferential bioavailability of SPARC in the liver and pancreas during T1DM in terms of tissue remodelling and β-cell function, respectively. This evidence concerns the gene SPARC and type 1 diabetes mellitus.